The draft guidance recommends secukinumab for treating patients with active ankylosing spondylitis in adults when non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors have failed or are not recommended.
You Might Also Like
Also By This Author
Michele B. Kaufman, PharmD, CGP, RPh, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.
- Radius Health Inc. News release: JAMA publishes positive phase III data for abaloparatide in postmenopausal women with osteoporosis. 2016 Aug 16.
- Miller PD, Hattersley G, Riis BJ, et al. Effect of abaloparatide vs. placebo on new vertebral fractures in postmenopausal women with osteoporosis: A randomized clinical trial. 2016 Aug 16;316(7):722-733. doi: 10.1001/jama.2016.11136.
- Staff. NICE draft guidance recommends new drug for people with ankylosing spondylitis. FirstWord Pharma. 2016 Aug 8.